Levine GN, McEvoy JW, Fang JC, Ibeh C, McCarthy CP, Misra A, Shah ZI, Shenoy C, Spinler SA, Vallurupalli S, Lip GYH. Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association. Circulation. 2022;146:e205–23.

Article  PubMed  Google Scholar 

McCarthy CP, Murphy S, Venkateswaran RV, Singh A, Chang LL, Joice MG, Rivero JM, Vaduganathan M, Januzzi JL, Bhatt DL. Left ventricular thrombus: contemporary etiologies, treatment strategies, and outcomes. J Am Coll Cardiol. 2019;73:2007–9.

Article  PubMed  Google Scholar 

McCarthy CP, Vaduganathan M, McCarthy KJ, Januzzi JL, Bhatt DL, McEvoy JW. Left ventricular thrombus after acute myocardial infarction: screening, prevention, and treatment. JAMA Cardiology. 2018;3:642–9.

Article  PubMed  Google Scholar 

Lattuca B, Bouziri N, Kerneis M, Portal J-J, Zhou J, Hauguel-Moreau M, Mameri A, Zeitouni M, Guedeney P, Hammoudi N, et al. Antithrombotic therapy for patients with left ventricular mural thrombus. J Am Coll Cardiol. 2020;75:1676–85.

Article  CAS  PubMed  Google Scholar 

O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e362–425.

PubMed  Google Scholar 

Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–91.

Article  CAS  PubMed  Google Scholar 

Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363:2499–510.

Article  CAS  PubMed  Google Scholar 

Youssef AA, Alrefae MA, Khalil HH, Abdullah HI, Khalifa ZS, Al Shaban AA, Wali HA, AlRajab MR, Saleh OM, Nashy BN. Apixaban in patients with post-myocardial infarction left ventricular thrombus: a randomized clinical trial. CJC Open. 2023;5:191–9.

Article  PubMed  Google Scholar 

Yang Q, Quan X, Wang C, Yu L, Yang Y, Zhu J, Liang Y. A prediction model for left ventricular thrombus persistence/recurrence: based on a prospective study and a retrospective study. Thromb J. 2023;21:50.

Article  PubMed  PubMed Central  Google Scholar 

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical Research ed). 2009;339:b2700.

Article  PubMed  Google Scholar 

Seiler T, Vasiliauskaite E, Grüter D, Young M, Attinger-Toller A, Madanchi M, Cioffi GM, Tersalvi G, Müller G, Stämpfli SF, et al. Direct oral anticoagulants versus vitamin K antagonists for the treatment of left ventricular thrombi-insights from a swiss multicenter registry. Am J Cardiol. 2023;194:113–21.

Article  CAS  PubMed  Google Scholar 

Tamimi F, Elmariah H, Patel Y, Omar A, Naoulou B, Fox JT, Kanei Y. Management and clinical outcomes of left ventricular thrombus. J Am Coll Cardiol. 2022;79(9):361.

Herald J, Goitia J, Duan L, Chen A, Lee M-S. Safety and effectiveness of direct oral anticoagulants versus warfarin for treating left ventricular thrombus. Am J Cardiovasc Drugs. 2022;22:437–44.

Article  CAS  PubMed  Google Scholar 

Alcalai R, Butnaru A, Moravsky G, Yagel O, Rashad R, Ibrahimli M, Planer D, Amir O, Elbaz-Greener G, Leibowitz D. Apixaban vs. warfarin in patients with left ventricular thrombus: a prospective multicentre randomized clinical trial‡. Eur Heart J Cardiovasc Pharmacother. 2022;8:660–7.

Article  PubMed  Google Scholar 

Albabtain MA, Alhebaishi Y, Al-Yafi O, Kheirallah H, Othman A, Alghosoon H, Arafat AA, Alfagih A. Rivaroxaban versus warfarin for the management of left ventricle thrombus. Egypt Heart J. 2021;73:41.

Article  PubMed  PubMed Central  Google Scholar 

Isa WW, Haniff Y, Hwong N, Yusof AM, Yusof Z, Loong NS, Wan-Arfah N, Naing N. Apixaban versus Warfarin in Patients with Left Ventricular Thrombus: A Pilot Prospective Randomized Outcome Blinded Study Investigating Size Reduction or Resolution of Left Ventricular Thrombus. J Clin Prev Cardiol. 2020;9:150–54.

Mihm AE, Hicklin HE, Cunha AL, Nisly SA, Davis KA. Direct oral anticoagulants versus warfarin for the treatment of left ventricular thrombosis. Intern Emerg Med. 2021;16:2313–7.

Article  PubMed  Google Scholar 

Xu Z, Li X, Li X, Gao Y, Mi X. Direct oral anticoagulants versus vitamin K antagonists for patients with left ventricular thrombus. Ann Palliat Med. 2021;10:9427–34.

Article  PubMed  Google Scholar 

Varwani MH, Shah J, Ngunga M, Jeilan M. Treatment and outcomes in patients with left ventricular thrombus - experiences from the Aga Khan University Hospital, Nairobi - Kenya. Pan Afr Med J. 2021;39:212.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Z, Si D, Zhang Q, Qu M, Yu M, Jiang Z, Li D, Yang P, Zhang W. Rivaroxaban versus Vitamin K Antagonists (warfarin) based on the triple therapy for left ventricular thrombus after ST-Elevation myocardial infarction. Heart Vessels. 2022;37:374–84.

Article  PubMed  Google Scholar 

Bass ME, Kiser TH, Page RL, McIlvennan CK, Allen LA, Wright G, Shakowski C. Comparative effectiveness of direct oral anticoagulants and warfarin for the treatment of left ventricular thrombus. J Thromb Thrombolysis. 2021;52:517–22.

Article  CAS  PubMed  Google Scholar 

Minciunescu A, ljaz N, Donthi N, Genovese LD, Tehrani BN, Tran HA. Direct Oral anticoagulants compared to warfarin for the treatment of left ventricular Thrombus: a multi-center experience. Circulation. 2020;142:A16816.

Jones DA, Wright P, Alizadeh MA, Fhadil S, Rathod KS, Guttmann O, Knight C, Timmis A, Baumbach A, Wragg A, et al. The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction. Eur Heart J Cardiovasc Pharmacother. 2021;7:398–404.

Article  PubMed  Google Scholar 

Iqbal H, Straw S, Craven TP, Stirling K, Wheatcroft SB, Witte KK. Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus. ESC Heart Failure. 2020;7:2032–41.

Article  PubMed  PubMed Central  Google Scholar 

Willeford A, Zhu W, Stevens C, Thomas IC. Direct oral anticoagulants versus warfarin in the treatment of left ventricular thrombus. Ann Pharmacother. 2021;55:839–45.

Article  CAS  PubMed  Google Scholar 

Yunis A, Seese LM, Stearns B, Genuardi MV, Thoma FW, Kilic A. Direct oral anticoagulants are effective therapy in treating left ventricular thrombi. J Am College Cardiol. 2020;75:948.

Article  Google Scholar 

Cochran JM, Jia X, Kaczmarek J, Staggers KA, Rifai MA, Hamzeh IR, Birnbaum Y. Direct oral anticoagulants in the treatment of left ventricular thrombus: a retrospective, multicenter study and meta-analysis of existing data. J Cardiovasc Pharmacol Ther. 2021;26:173–8.

Article  CAS  PubMed  Google Scholar 

Robinson AA, Trankle CR, Eubanks G, Schumann C, Thompson P, Wallace RL, Gottiparthi S, Ruth B, Kramer CM, Salerno M, et al. Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi. JAMA Cardiol. 2020;5:685–92.

Article  PubMed  PubMed Central  Google Scholar 

Guddeti RR, Anwar M, Walters RW, Apala D, Pajjuru V, Kousa O, Gujjula NR, Alla VM. Treatment of left ventricular thrombus with direct oral anticoagulants: a retrospective observational study. Am J Med. 2020;133:1488–91.

Article  CAS  PubMed  Google Scholar 

Ali Z, Isom N, Dalia T, Sami F, Mahmood U, Shah Z, Gupta K. Direct oral anticoagulant use in left ventricular thrombus. Thromb J. 2020;18:29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Daher J, Da Costa A, Hilaire C, Ferreira T, Pierrard R, Guichard JB, Romeyer C, Isaaz K. Management of left ventricular thrombi with direct oral anticoagulants: retrospective comparative study with vitamin K antagonists. Clin Drug Investig. 2020;40:343–53.

Article  CAS  PubMed  Google Scholar 

Gama F, Freitas P, Trabulo M, Ferreira AM, Andrade MJ, Matos D, Strong C, Ribeiras R, Ferreira JMS, Mendes M. 459Direct oral anticoagulants are an effective therapy for left ventricular thrombus formation. Eur Heart J. 2019;40:ehz747.

Article  Google Scholar 

Jaidka AK, Zhu T, Lavi S, Johri A. Treatment of left ventricular thrombus using warfarin versus direct oral anticoagulants following anterior myocardial infarction. Can J Cardiol. 2018;34:S143.

Article  Google Scholar 

Lim CW, Mamat R, Hishammudin IA, Danuri N, Khir RN, Ibrahim KS, Radzi ABM, Chua NYC, Ismail JR, Abidin HAZ, Kasim S. Left ventricular thrombus: patient characteristics and treatment from a single tertiary centre’s experience. Int J Cardiol. 2019;297:20–1.

Article  Google Scholar 

Abdelnabi M, Saleh Y, Fareed A, Nossikof A, Wang L, Morsi M, Eshak N, Abdelkarim O, Badran H, Almaghraby A. Comparative study of oral anticoagulation in left ventricular thrombi (No-LVT Trial). J Am Coll Cardiol. 2021;77:1590–2.

Article  PubMed  Google Scholar 

Robinson AA, Jain A, Gentry M, McNamara RL. Left ventricular thrombi after STEMI in the primary PCI era: a systematic review and meta-analysis. Int J Cardiol. 2016;221:554–9.

Article  PubMed  Google Scholar 

Lee JM, Park JJ, Jung HW, Cho Y-S, Oh I-Y, Yoon C-H, Suh J-W, Chun EJ, Choi SI, Youn T-J, et al. Left ventricular thrombus and subsequent thromboembolism, comparison of anticoagulation, surgical removal, and antiplatelet agents. J Atheroscler Thromb. 2013;20:73–93.

Article  PubMed  Google Scholar 

Vaitkus PT, Barnathan ES. Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis. J Am Coll Cardiol. 1993;22:1004–9.

Article  CAS  PubMed  Google Scholar 

Watson T, Shantsila E, Lip GYH. Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet (London, England). 2009;373:155–66.